You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Magrolimab

Showing 1 - 25 of 28
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome, Relapsed/Refractory Acute Myeloid Leukemia Trial (Magrolimab)

Available
  • Relapsed/Refractory Higher-Risk Myelodysplastic Syndrome
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Magrolimab
  • (no location specified)
Jan 18, 2023

MDS Trial (Decitabine/Cedazuridine, Magrolimab)

Not yet recruiting
  • Myelodysplastic Syndromes
  • (no location specified)
Apr 18, 2023

MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 2, 2022

Advanced Urothelial Carcinoma Trial in Bern (Magrolimab, Cisplatin, Gemcitabine)

Not yet recruiting
  • Advanced Urothelial Carcinoma
  • Magrolimab
  • +2 more
  • Bern, Switzerland
    University Hospital Insel
Feb 20, 2023

Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Neoplasm
  • Magrolimab
  • +2 more
  • (no location specified)
Apr 24, 2023

Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

Recruiting
  • Follicular Lymphoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,

Recruiting
  • Hodgkin Lymphoma
  • +3 more
  • Magrolimab
  • +2 more
  • Stanford, California
    Stanford University
Jun 21, 2022

Multiple Myeloma Trial in United States (Magrolimab, Daratumumab, Pomalidomide)

Recruiting
  • Multiple Myeloma
  • Magrolimab
  • +5 more
  • Tucson, Arizona
  • +8 more
Jul 28, 2022

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial (procedure, biological,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Apr 8, 2023

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte (procedure, drug, biological, other)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Apr 10, 2023

Hematological Malignancies Trial in United Kingdom, United States (Magrolimab, Azacitidine)

Active, not recruiting
  • Hematological Malignancies
  • Duarte, California
  • +26 more
Dec 7, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)

Recruiting
  • Myeloid Malignancies
  • Magrolimab
  • +6 more
  • Birmingham, Alabama
  • +12 more
Apr 6, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Magrolimab
  • +4 more
  • Duarte, California
  • +19 more
Jan 27, 2023

Mycosis Fungoides, Recurrent Mycosis Fungoides, Recurrent Mycosis Fungoides and Sezary Syndrome Trial in United States

Recruiting
  • Mycosis Fungoides
  • +11 more
  • Biospecimen Collection
  • +5 more
  • Duarte, California
  • +12 more
Jan 7, 2023

Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)

Active, not recruiting
  • Non Hodgkin Lymphoma
  • Magrolimab
  • +3 more
  • Birmingham, Alabama
  • +19 more
Dec 8, 2022

Solid Tumor Trial in Poland, Spain, United States (Magrolimab, Docetaxel)

Recruiting
  • Solid Tumor
  • Goodyear, Arizona
  • +43 more
Jan 11, 2023

Ovarian Cancer Trial in United States (Magrolimab, Avelumab)

Completed
  • Ovarian Cancer
  • Chicago, Illinois
  • +5 more
Jul 26, 2021

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +6 more
  • Duarte, California
  • +25 more
Feb 4, 2022

Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Magrolimab
  • +6 more
  • Chandler, Arizona
  • +59 more
Jan 20, 2023

Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)

Completed
Has Results
  • Solid Tumor
  • Colorectal Cancer
  • Los Angeles, California
  • +7 more
Feb 8, 2021

Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)

Recruiting
  • Acute Myeloid Leukemia
  • Magrolimab
  • +3 more
  • Little Rock, Arkansas
  • +82 more
Jan 17, 2023

MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Magrolimab
  • +2 more
  • Birmingham, Alabama
  • +168 more
Dec 7, 2022

NHL, DLBCL, Non-hodgkin's Lymphoma Trial in United Kingdom, United States (AZD9150, Acalabrutinib, AZD6738)

Completed
  • NHL
  • +3 more
  • Los Angeles, California
  • +11 more
Aug 11, 2022